These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 10980055
1. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. McLaughlin K, Wajstaub S, Marotta P, Adams P, Grant DR, Wall WJ, Jevnikar AM, Rizkalla KS. Liver Transpl; 2000 Sep; 6(5):570-4. PubMed ID: 10980055 [Abstract] [Full Text] [Related]
2. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hézode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens AL, Gaulard P, Cherqui D, Pawlotsky JM, Dhumeaux D. Hepatology; 1999 Sep; 30(3):775-8. PubMed ID: 10462385 [Abstract] [Full Text] [Related]
3. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME. Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581 [Abstract] [Full Text] [Related]
4. Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation. Zhang A, Zhang M, Shen Y, Wang W, Zheng S. Clin Transplant; 2009 Jul 15; 23(5):756-60. PubMed ID: 19664018 [Abstract] [Full Text] [Related]
5. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Transplantation; 2003 Nov 15; 76(9):1289-93. PubMed ID: 14627905 [Abstract] [Full Text] [Related]
6. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P. Transplant Proc; 2005 May 15; 37(4):1700-2. PubMed ID: 15919436 [Abstract] [Full Text] [Related]
7. Transplantation in the patient with hepatitis C. Domínguez-Gil B, Morales JM. Transpl Int; 2009 Dec 15; 22(12):1117-31. PubMed ID: 19656350 [Abstract] [Full Text] [Related]
8. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr 15; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related]
9. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center. Quintini C, Kato T, Gaynor JJ, Ueno T, Selvaggi G, Gordon P, McLaughlin G, Tompson J, Ruiz P, Tzakis A. Transplant Proc; 2006 Apr 15; 38(6):1755-8. PubMed ID: 16908272 [Abstract] [Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965 [Abstract] [Full Text] [Related]
11. Development of lymphoproliferative disease after liver transplantation. Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E. Transplant Proc; 2008 Nov 15; 40(9):2988-9. PubMed ID: 19010169 [Abstract] [Full Text] [Related]
12. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center]. Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J. Nefrologia; 2002 Nov 15; 22(5):463-9. PubMed ID: 12497748 [Abstract] [Full Text] [Related]
13. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Liver Transpl; 2004 Aug 15; 10(8):975-85. PubMed ID: 15390322 [Abstract] [Full Text] [Related]
14. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Birkeland SA, Hamilton-Dutoit S. Transplantation; 2003 Sep 27; 76(6):984-8. PubMed ID: 14508366 [Abstract] [Full Text] [Related]
15. Posttransplant lymphoproliferative disorders in transplant recipients. Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A. Transplant Proc; 2006 Mar 27; 38(2):641-5. PubMed ID: 16549195 [Abstract] [Full Text] [Related]
16. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome. Watt KD, Lyden ER, Gulizia JM, McCashland TM. Liver Transpl; 2006 Jan 27; 12(1):134-9. PubMed ID: 16382465 [Abstract] [Full Text] [Related]
17. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW. Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085 [Abstract] [Full Text] [Related]
18. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R. Transplant Proc; 2008 Nov 15; 40(9):2994-6. PubMed ID: 19010171 [Abstract] [Full Text] [Related]
19. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality. Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS. J Pediatr Surg; 2008 Dec 15; 43(12):2174-7. PubMed ID: 19040929 [Abstract] [Full Text] [Related]
20. Post-transplant lymphoproliferative disorders after live donor renal transplantation. Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK. Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560 [Abstract] [Full Text] [Related] Page: [Next] [New Search]